Skip to main content
SpringerLink
Log in

A Critical Review of SERVE-HF Follow-Up Studies and Their Impact on Clinical Practice

  • Heart Disease and Sleep Disturbances (R Khayat, Section Editor)
  • Published:
Current Sleep Medicine Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The SERVE-HF trial results were widely interpreted as strong evidence that adaptive servo-ventilation was contraindicated for the treatment of central sleep apnea/Hunter-Cheyne-Stokes breathing in patients with heart failure and reduced ejection fraction. Subsequently, the investigators have published five follow-up analyses of the study data. This paper will review these publications and provide additional commentary meant to provide updated context concerning this important subject.

Recent Findings

The investigators have analyzed their dataset using different approaches and extracted additional information. Inevitably, some of the original criticisms leveled at SERVE-HF continue to apply, but most add important new information concerning their endeavor. One of these studies provided an on-treatment analysis that supported the original findings, while another reinforced the likelihood that excess mortality in the active treatment arm was due to a cardio-electrical event during wakefulness. A third study concentrated on patients with the HCSB pattern of CSA and revealed a relationship between cycle length and the primary composite endpoint in subjects belonging to both the active treatment arms and the control group. This analysis is of interest for the study of heart failure in general and did not necessarily confirm or clarify the findings of the original study.

Summary

The most important paradigm shift in the management of central sleep apnea in patients with systolic heart failure is attributable to SERVE-HF. The results of the trial contradicted all heretofore accepted evidence in the field including the assumptions of its investigators. While the primary outcome of the trial was negative, the main reported finding of this was driven by an exploratory analysis that was not part of the statistical original design of the trial and that could not be explained by any mechanistic analysis from the trial data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Brown LK, Javaheri S. Adaptive servo-ventilation for the treatment of central sleep apnea in congestive heart failure: what have we learned? Curr Opin Pulm Med. 2014;20:550–7.

    Article  PubMed  Google Scholar 

  2. Javaheri S, Brown LK, Randerath WJ. Positive airway pressure therapy with adaptive servoventilation: part 1: operational algorithms. Chest. 2014;146:514–23.

    Article  PubMed  Google Scholar 

  3. • Johnson KG, Johnson DC. Treatment of sleep-disordered breathing with positive airway pressure devices: technology update. Med Devices (Auckl). 2015;8:425–37 For readers who wish to know how a positive airway pressure flow generator works. Beware: very technical!

  4. • Brown LK, Javaheri S. Positive airway pressure device technology past and present: what’s in the “black box”? Sleep Med Clin. 2017;12:501–15 For readers who wish to know how a positive airway pressure flow generator works. Beware: very technical!

  5. Randerath WJ, Galetke W, Stieglitz S, Laumanns C, Schäfer T. Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnoea and Cheyne-Stokes respiration. Sleep Med. 2008;9:823–30.

    Article  PubMed  Google Scholar 

  6. Arzt M, Wensel R, Montalvan S, Schichtl T, Schroll S, Budweiser S, et al. Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest. 2008;134:61–6.

    Article  PubMed  Google Scholar 

  7. Randerath WJ, Galetke W, Kenter M, Richter K, Schäfer T. Combined adaptive servo-ventilation and automatic positive airway pressure (anticyclic modulated ventilation) in co-existing obstructive and central sleep apnea syndrome and periodic breathing. Sleep Med. 2009;10:898–903.

    Article  PubMed  Google Scholar 

  8. • Teschler H, Dohring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med. 2001;164:614–9 The seminal article describing the efficacy of adaptive servo-ventilation compared with multiple other modalities.

  9. Szollosi I, O’Driscoll DM, Dayer MJ, Coats AJ, Morrell MJ, Simonds AK. Adaptive servo-ventilation and deadspace: effects on central sleep apnoea. J Sleep Res. 2006;15:199–205.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang X, Yin K, Li X, Jia E, Su M. Efficacy of adaptive servoventilation in patients with congestive heart failure and Cheyne-Stokes respiration. Chin Med J. 2006;119:622–7.

    Article  PubMed  Google Scholar 

  11. Banno K, Okamura K, Kryger MH. Adaptive servo-ventilation in patients with idiopathic Cheyne-Stokes breathing. J Clin Sleep Med. 2006;2:181–186.10.

    Article  PubMed  Google Scholar 

  12. Fietze I, Blau A, Glos M, Theres H, Baumann G, Penzel T. Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Med. 2008;9:652–9.

    Article  PubMed  Google Scholar 

  13. Campbell AJ, Ferrier K, Neill AM. The effect of oxygen versus adaptive pressure support servo-ventilation in patients with central sleep apnea-Cheyne Stokes respiration and congestive heart failure. Intern Med J. 2012;42:1130–6.

    Article  CAS  PubMed  Google Scholar 

  14. Javaheri S, Winslow D, McCullough P, Wylie P, Kryger MH. The use of a fully automated automatic adaptive servoventilation algorithm in the acute and long-term treatment of central sleep apnea. Chest. 2015;148:1454–61.

    Article  PubMed  Google Scholar 

  15. •• Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015;373:1095–105 The paper that started the controversy concerning adaptive servo-ventilation for the treatment of central sleep apnea/Hunter-Cheyne-Stokes breathing in patients with heart failure and reduced ejection fraction.

  16. Randerath W, Verbraecken J, Andreas S, Arzt M, et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J. 2017;49:160095.

    Article  Google Scholar 

  17. • Javaheri S, Brown LK, Randerath W, Khayat R. SERVE-HF: More questions than answers [commentary]. Chest. 2016;149:900–4 A comprehensive analysis of SERVE-HF questioning whether the trial justifies the recommendations about adaptive servo-ventilation that it provoked.

  18. Randerath W, Khayat R, Arzt M, Javaheri S. Missing links. Sleep Med. December 2015;16(12):1495–6.

    Article  CAS  PubMed  Google Scholar 

  19. Knitter J, Bailey OF, Poongkunran C, Martinez AF, et al. Comparison of physiological performance of four adaptive servo ventilation devices in patients with complex sleep apnea. Am J Respir Crit Care Med. 2019;199:925–8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sliwiński M, Hoffman M, Biederman A, Wangin H, Holdrowicz M. Association between hypokaliaemic alkalosis and development of arrhythmia in early postoperative period. Anaesth Resusc Intensive Ther. 1974;2:193–204.

    PubMed  Google Scholar 

  21. Berger KI, Norman RG, Ayappa I, Oppenheimer BW, Rapoport DM, Goldring RM. Potential mechanism for transition between acute hypercapnia during sleep to chronic hypercapnia during wakefulness in obstructive sleep apnea. Adv Exp Med Biol. 2008;605:431–6.

    Article  PubMed  Google Scholar 

  22. Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d’Ortho MP, Erdmann E, et al. Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med. 2016;4:873–81.

    Article  PubMed  Google Scholar 

  23. •• Woehrle H, Cowie MR, Eulenburg C, et al. Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis. Eur Respir J. 2017;50:1601692. https://doi.org/10.1183/13993003.01692-2016Although still somewhat flawed, a re-analysis of SERVE-HF data that further supports the proscription against using adaptive servo-ventilation in patients with central sleep apnea/Hunter-Cheyne-Stokes breathing and heart failure with reduced ejection fraction.

  24. Shrier I, Verhagen E, Stovitz SD. The intention-to-treat analysis is not always the conservative approach. Am J Med. 2017;130:867–71.

    Article  PubMed  Google Scholar 

  25. Bradley TD. SERVE-HF on-treatment analysis: does the on-treatment analysis SERVE its purpose? Eur Respir J. 2017;50:1701516. https://doi.org/10.1183/13993003.01516-2017.

    Article  PubMed  Google Scholar 

  26. Cowie MR, Woehrle H, Wegscheider, et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. Eur J Heart Fail. 2018;20:536–44.

    Article  PubMed  Google Scholar 

  27. • Javed F, Tamisier R, Pepin JL, Cowie MR, et al. Association of serious adverse events with Cheyne-Stokes respiration characteristics in patients with systolic heart failure and central sleep apnoea: A SERVE-Heart Failure substudy analysis. Respirology. 2019. https://doi.org/10.1111/resp.13613An interesting analysis of SERVE-HF data that may shed further light on the pathogenesis and implications of Hunter-Cheyne-Stokes breathing in heart failure.

  28. Javed F, Fox H, Armitstead J. ResCSRF: algorithm to automatically extract Cheyne-Stokes respiration features from respiratory signals. IEEE Trans Biomed Eng. 2018;65:669–77.

    Article  PubMed  Google Scholar 

  29. Javaheri S, Brown LK, Khayat R. CON: persistent central sleep apnea/hunter-Cheyne-Stokes breathing, despite best guideline-based therapy of heart failure with reduced ejection fraction, Is Not a Compensatory Mechanism and Should Be Suppressed. J Clin Sleep Med. 2018;14:915–21.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Festic E. Baseline use of antiarrhythmics in patients given adaptive servoventilation: SERVE-HF. Lancet Respir Med. 2017;5:e4. https://doi.org/10.1016/S2213-2600(16)30429-5.

    Article  PubMed  Google Scholar 

  31. Eulenburg C, Wegscheider K, Woehrle H, Cowie MR. Baseline use of antiarrhythmics in patients given adaptive servoventilation: SERVE-HF-authors’ reply. Lancet Respir Med. 2017;5:e5. https://doi.org/10.1016/S2213-2600(16)30428-3.

    Article  PubMed  Google Scholar 

  32. Pocock SJ, Clayton TC, Stone GW. Design of major randomized trials. Part 3 of a 4-part series on statistics for clinical trials. J Am Coll Cardiol. 2015;66:2757–66.

    Article  PubMed  Google Scholar 

  33. •• O’Neill RT. Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significance. Control Clin Trials. 1997;18:550–6 Reinforces the view that secondary endpoints are hypothesis-generating only and should be acted on with caution.

  34. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303:2058–64.

    Article  CAS  PubMed  Google Scholar 

  35. Davis CE. Secondary endpoints can be validly analyzed, even if the primary endpoint does not provide clear statistical significance. Control Clin Trials. 1997;18:557–60.

    Article  CAS  PubMed  Google Scholar 

  36. Gong J, Pinheiro JC, DeMets DL. Estimating significance level and power comparisons for testing multiple endpoints in clinical trials. Control Clin Trials. 2000;21:313–29.

    Article  CAS  PubMed  Google Scholar 

  37. Benjamini Y, Cohen R. Weighted false discovery rate controlling procedures for clinical trials. Biostatistics. 2017;18:91–104.

    Article  PubMed  Google Scholar 

  38. Srinivas TR, Ho B, Kang J, Kaplan B. Post hoc analyses. After the facts. Tranplantation. 2015;99:17–20.

    Article  Google Scholar 

  39. Maciejewski ML, Brookhart MA. Using instrumental variables to address bias from unobserved confounders. JAMA. 2019;321:2124–2125.41.

    Article  PubMed  Google Scholar 

  40. • Bauchner H. The rush to publication: an editorial and scientific mistake. JAMA. 2017;318:1109–10 Describing an unfortunate trend in current medical publishing: trying to “scoop” other journals by publishing seemingly important papers without adequate peer review.

  41. • Shahzeb Khan M, Lateef N, Siddiqi TJ, et al. Level and prevalence of spin in published cardiovascular randomized trial reports with statistically nonsignificant primary outcomes. A systematic review. JAMA Netw Open. 2019;2:e192622. https://doi.org/10.1001/jamanetworkopen.2019.2622Another unfortunate trend in current medical publishing: exaggerating the importance of secondary outcomes.

  42. Linz D, Fox H, Bitter T, Spießhöfer J, Schöbel C, Skobel E, et al. Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies. Clin Res Cardiol. 2016;105:563–70.

    Article  CAS  PubMed  Google Scholar 

  43. Fiuzat M, Oldenberg O, Whellan DJ, Woehrle H, Punjabi NM, Anstrom KJ, et al. Lessons learned from a clinical trial: design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) study. Contemp Clin Trials. 2016;47:158–64.

    Article  PubMed  Google Scholar 

  44. O’Connor CM, Whellan DJ, Fiuzat M, et al. Cardiovascular outcomes with minute ventilation-targeted adaptive servo-ventilation therapy in heart failure: the CAT-HF trial. J Am Coll Cardiol. 2017;69:1577–87.

    Article  PubMed  Google Scholar 

  45. Brill AK, Pichler Hefti J, Geiser T, Ott SR. The SERVE-HF safety notice in clinical practice—experiences of a tertiary sleep center. Sleep Med. 2017;37:201–7.

    Article  PubMed  Google Scholar 

  46. Hetland A, Lerum TV, Haugaa KH, Edvardsen T. Patients with Cheyne-Stokes respiration and heart failure: patient tolerance after three-month discontinuation of treatment with adaptive servo-ventilation. Heart Vessel. 2017;32:909–15.

    Article  Google Scholar 

  47. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603. https://doi.org/10.1161/CIR.0000000000000485.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Khayat R, Jarjoura D, Patt B, Yamokoski T, et al. In-hospital testing for sleep-disordered breathing in hospitalized patients with decompensated heart failure. J Cardiac Fail. 2009;15:739–46.

    Article  Google Scholar 

  49. Donovan LM, Kapur VK. Prevalence and characteristics of central compared to obstructive sleep apnea: analyses from the sleep heart health study cohort. Sleep. 2016;39:1353–9.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Malfertheiner MV, Lerzer C, Kolb L, Heider K, Zeman F, Gfüllner F, et al. Whom are we treating with adaptive servo-ventilation? A clinical post hoc analysis. Clin Res Cardiol. 2017;106:702–10.

    Article  PubMed  Google Scholar 

  51. Randerath W, Schumann K, Treml M, Herkenrath S, Castrogiovanni A, Javaheri S, et al. Adaptive servoventilation and clinical practice: beyond SERVE-HF? ERJ Open Res. 2017;3:00078–2017. https://doi.org/10.1183/23120541.00078-2017.

    Article  PubMed  PubMed Central  Google Scholar 

  52. •• Lyons OD, Floras JS, Logan AG, ADVENT-HF Investigators, et al. Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial. Eur J Heart Fail. 2017;19(4):579–87 An important ongoing trial of adaptive servo-ventilation for the treatment of sleep apnea in patients with heart failure. Although concentrating more heavily on obstructive sleep apnea, aspects of the trial should be relevant to central sleep disordered breathing as well.

  53. • Costanzo MR, Ponikowski P, Javaheri S, remedé System Pivotal Trial Study Group, et al. Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. Lancet. 2016;388:974–82 Describes the technology and efficacy of transvenous phrenic nerve stimulation for the treatment of central sleep apnea.

  54. • Jaffuel D, Molinari N, Berdague, et al. Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design. ESC Heart Failure. 2018;5:222–30 A new drug combination that may change the guideline-directed therapy of heart failure, and consequently disrupt ongoing heart failure trials in general. Fortunately, this trial concentrates on possible amelioration of sleep apnea in heart failure.

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA

    Lee K. Brown

  2. Program in Sleep Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA

    Lee K. Brown

  3. Department of Electrical and Computer Engineering, University of New Mexico School of Engineering, Albuquerque, NM, USA

    Lee K. Brown

  4. Bethesda North Hospital, Cincinnati, OH, USA

    Shahrokh Javaheri

  5. University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Shahrokh Javaheri

  6. Division of Cardiology, The Ohio State University, Columbus, OH, USA

    Shahrokh Javaheri

  7. Division of Pulmonary and Critical Care, California-Irvine State University, Albuquerque, NM, 87106, USA

    Rami Khayat

  8. Department of Psychiatry and Human Behavior, California-Irvine State University, Irvine, CA, 92697, USA

    Rami Khayat

Authors
  1. Lee K. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahrokh Javaheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rami Khayat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lee K. Brown.

Ethics declarations

Conflict of Interest

The authors have no conflicts of interest to declare.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Heart Disease and Sleep Disturbances

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brown, L.K., Javaheri, S. & Khayat, R. A Critical Review of SERVE-HF Follow-Up Studies and Their Impact on Clinical Practice. Curr Sleep Medicine Rep 6, 149–156 (2020). https://doi.org/10.1007/s40675-020-00177-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40675-020-00177-9

Keywords

Search

Navigation